This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for a revision of the indication for use statement to read "for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to macular degeneration, presumed ocular histoplasmosis, or pathologic myopia. "
Device | VISULAS 690S AND VISULINK PDT/U ADAPTER |
Classification Name | System, Laser, Photodynamic Therapy |
Generic Name | System, Laser, Photodynamic Therapy |
Applicant | CARL ZEISS MEDITEC AG |
Date Received | 2000-08-14 |
Decision Date | 2001-09-27 |
PMA | P990048 |
Supplement | S001 |
Product Code | MVF |
Advisory Committee | General & Plastic Surgery |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | CARL ZEISS MEDITEC AG 5160 Hacienda Drive dublin, CA 94568 |
Supplement Number | Date | Supplement Type |
---|---|---|
P990048 | Original Filing | |
S003 | 2008-04-22 | Normal 180 Day Track |
S002 | 2001-03-09 | Normal 180 Day Track |
S001 | 2000-08-14 | Normal 180 Day Track |